Matthew James Large, Aishah Bashiri, Yashiv Dookie, Joanne McNamara, Luca Antognini, Saba Aziz, Lucio Calcagnile, Anna Paola Caricato, Roberto Catalano, Deborah Chila, Giuseppe Antonio Pablo Cirrone, Tomasso Croci, Giacomo Cuttone, Sylvain Dunand, Michele Fabi, Luca Frontini, Catia Grimani, Maria Ionica, Keida Kanxheri, Valentino Liberali, Martino Maurizio, Giuseppe Maruccio, Giovanni Mazza, Mauro Menichelli, Anna Grazia Monteduro, Arianna Morozzi, Francesco Moscatelli, Stefania Pallotta, Daniele Passeri, Maddalena Pedio, Giada Petringa, Francesca Peverini, Lorenzo Piccolo, Pisana Placidi, Gianluca Quarta, Silvia Rizzato, Federico Sabbatini, Leonello Servoli, Alberto Stabile, Cinzia Talamonti, Jonathan Emanuel Thomet, Luca Tosti, Mattia Villani, Richard James Wheadon, Nicolas Wyrsch, Nicola Zema, Marco Petasecca
BACKGROUND: The increasing use of complex and high dose-rate treatments in radiation therapy necessitates advanced detectors to provide accurate dosimetry. Rather than relying on pre-treatment quality assurance (QA) measurements alone, many countries are now mandating the use of in vivo dosimetry, whereby a dosimeter is placed on the surface of the patient during treatment. Ideally, in vivo detectors should be flexible to conform to a patient's irregular surfaces. PURPOSE: This study aims to characterize a novel hydrogenated amorphous silicon (a-Si:H) radiation detector for the dosimetry of therapeutic x-ray beams...
March 3, 2024: Medical Physics